Screening for Osteoporosis in Older Men: Operating Characteristics of Proposed Strategies for Selecting Men for BMD Testing

• DOI: 10.1007/s11606-017-4153-4
• Publication Date: 2017-08-16T19:56:50Z
• Authors: Susan J. Diem; Katherine W. Peters; Margaret L. Gourlay; John T. Schousboe; Brent C. Taylor; Eric S. Orwoll; Jane A. Cauley; Lisa Langsetmo; Carolyn J. Crandall; Kristine E. Ensrud
• Keywords: Aged, 80 and over; Male; 3. Good health; Cohort Studies; 03 medical and health sciences; 0302 clinical medicine; ROC Curve; Bone Density; Risk Factors; Humans; Mass Screening; Osteoporosis; Prospective Studies; Aged

The optimal approach for selecting men for bone mineral density (BMD) testing to screen for osteoporosis is uncertain.To compare strategies for selecting older men for screening BMD testing.Prospective cohort study.A total of 4043 community-dwelling men aged ≥70 years at four US sites.BMD at the total hip, femoral neck, and lumbar spine using dual-energy x-ray absorptiometry (DXA). Sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio, negative likelihood ratio, and area under the receiver operating curve (AUC) of the Osteoporosis Self-Assessment Tool (OST) and Fracture Risk Assessment Tool (FRAX) without BMD to discriminate between those with and without osteoporosis as defined by World Health Organization (WHO) diagnostic criteria, and between those recommended and not recommended for pharmacologic therapy based on the National Osteoporosis Foundation (NOF) guidelines.Among the cohort, 216 (5.3%) had a BMD T-score ≤ -2.5 at the femoral neck, total hip, or lumbar spine, and 1184 (29.2%) met criteria for consideration of pharmacologic therapy according to NOF guidelines. The OST had better discrimination (AUC 0.68) than the FRAX (AUC 0.62; p = 0.004) for identifying T-score-defined osteoporosis. Use of an OST threshold of <2 resulted in sensitivity of 0.83 and specificity of 0.36 for the identification of osteoporosis, compared to sensitivity of 0.59 and specificity of 0.59 for the use of FRAX with a cutoff of 9.3% 10-year risk of major osteoporotic fracture.The OST performs modestly better than the more complex FRAX in selecting older men for BMD testing to screen for osteoporosis; the use of either tool substantially reduces the proportion of men referred for BMD testing compared to universal screening. Of 1000 men aged 70 and older in this community-based cohort, the use of an OST cutoff of <2 to select men for BMD testing would result in 654 men referred for BMD testing, of whom 44 would be identified as having osteoporosis, and nine with osteoporosis would be missed.